Upload Avatar (500 x 500)
Bin Xu
Medical School
Wuhan University
Hubei
Language: English, Chinese
Lung Cancer
Clinical Translation
Tumor
Immune
Microenvironment
Precision Therapy
Research
Oncology
Treatment
Diagnosis
Cancer
Therapy
Clinical
Innovation
Areas of Focus
- Lung cancer research
- Tumor immune microenvironment and precision therapy
Work Experience
- 2011.07-2014.05: Resident Physician at Oncology Department, Renmin Hospital of Wuhan University
- 2014.06-2020.11: Attending Physician at Oncology Department, Renmin Hospital of Wuhan University
- 2020.12-present: Associate Chief Physician at Oncology Department, Renmin Hospital of Wuhan University
Academic Background & Achievements
- 2004.09-2011.06: Master's Degree in Clinical Medicine from Wuhan University
- 2013.09-2016.11: PhD in Internal Medicine from Wuhan University
- Second Prize of Hubei Province Science and Technology Progress Award
Publications
- Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer, Zuo Y, Zhong J, Bai H, Xu B et al., 2022
- A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma, Wu J, Li L, Zhang H, Zhao Y, Zhang H, Wu S, Xu B, 2021
- CMTM family proteins 1-8: roles in cancer biological processes and potential clinical value, Wu J, Li L, Wu S, Xu B, 2020
- Comprehensive Analysis Identifies and Validates the Tumor Microenvironment Subtypes to Predict Anti-Tumor Therapy Efficacy in Hepatocellular Carcinoma, Zhang H, Yao Y, Wu J, Zhou J, Zhao C, He J, Xu B, 2022
- Cancer mutation profiles predict ICIs efficacy in patients with non-small cell lung cancer, Zhu L, Ye D, Lei T, Wu J, Wang W, Xu B, 2022
- Oncolytic Adenovirus: Prospects for Cancer Immunotherapy, Zhao Y, Liu Z, Li L, Wu J, Zhang H, Zhang H, Lei T, Xu B, 2021
- Individualized model for predicting COVID-19 deterioration in patients with cancer: A multicenter retrospective study, Xu B, Song KH, Yao Y, et al., 2021
- Prognostic nomogram for predicting survival in patients with high grade endometrial stromal sarcoma: a Surveillance Epidemiology, and End Results database analysis, Wu J, Zhang H, Li L, Hu M, Chen L, Wu S, Xu B, Song Q, 2020
- Guanylate-Binding Protein 1 as a Potential Predictor of Immunotherapy: A Pan-Cancer Analysis, Zhao Y, Wu J, Li L, Zhang H, Zhang H, Li J, Zhong H, Lei T, Jin Y, Xu B, Song Q, 2022
Awards
- 2020: Second Prize of Hubei Province Science and Technology Progress Award for innovation and application of targeted and intelligent radiotherapy quality control system
- 2022: Highly Downloaded Paper on the development and prospects of tumor immunotherapy drugs
- 2014: Third Prize in the 2013 Annual Medical Education Excellent Papers by the Chinese Medical Association and the China Higher Education Society Medical Education Professional Committee
- 2019: Second Prize for Excellent Paper at the Annual Meeting of the Hubei Provincial Medical Association Radiation Oncology Branch
